Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Other financing activities (2022 - 2023)

Praxis Precision Medicines has reported Other financing activities over the past 2 years, most recently at $4.5 million for Q2 2023.

  • Quarterly results put Other financing activities at $4.5 million for Q2 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $4.5 million (up 1108.63% YoY), and the annual figure for FY2022 was $262000.0, down 54.43%.
  • Other financing activities for Q2 2023 was $4.5 million at Praxis Precision Medicines, up from $109000.0 in the prior quarter.
  • Over the last five years, Other financing activities for PRAX hit a ceiling of $4.5 million in Q2 2023 and a floor of $109000.0 in Q3 2022.